Avalo Therapeutics Inc (AVTX): .14 by Tuesday IMO

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	32
Posts	1650
Boards Moderated	0
Alias Born	12/19/2017

Meangene818

Re: INFINITI post# 1580

Friday, 12/15/2023 9:46:08 AM

Friday, December 15, 2023 9:46:08 AM

.14 by Tuesday IMO

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent AVTX News

Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/06/2024 04:15:06 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/05/2024 08:36:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 08:01:41 PM
Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/29/2024 08:08:55 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 08:23:55 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 08:17:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 11:36:46 AM
Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer • GlobeNewswire Inc. • 07/16/2024 11:00:00 AM
Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/11/2024 08:24:12 PM
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 07/11/2024 08:12:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 11:17:21 AM
Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer • GlobeNewswire Inc. • 06/24/2024 08:01:00 PM
Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit • GlobeNewswire Inc. • 06/17/2024 11:30:00 AM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 06/07/2024 11:01:10 AM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 06/06/2024 08:03:22 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 06/03/2024 11:20:28 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:01:22 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/13/2024 04:38:48 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 11:33:15 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 11:30:59 AM
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 05/13/2024 11:30:00 AM
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors • GlobeNewswire Inc. • 04/02/2024 11:00:00 AM
Avalo Reports 2023 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 03/29/2024 08:01:00 PM
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million • GlobeNewswire Inc. • 03/27/2024 08:01:00 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/15/2024 02:13:42 AM

More AVTX News

InvestorsHub NewsWire

Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM

Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM

Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM

North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM

Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM

Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover